Oncolytic Viruses in the Treatment of Bladder Cancer
Bladder carcinoma is the second most common malignancy of the urinary tract. Up to 85% of patients with bladder cancer are diagnosed with a tumor that is limited to the bladder mucosa (Ta, T1, and CIS). These stages are commonly termed as non-muscle-invasive bladder cancer (NMIBC). Although the trea...
| Hlavní autoři: | , , |
|---|---|
| Médium: | Článek |
| Jazyk: | English |
| Vydáno: |
Hindawi Limited
2012-01-01
|
| Edice: | Advances in Urology |
| On-line přístup: | http://dx.doi.org/10.1155/2012/404581 |